(Q44800864)

6 December 2017

title

Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis (English)

1 reference

6 December 2017

0 references

invasive aspergillosis

1 reference

3

1 reference

6 December 2017

7

1 reference

6 December 2017

1

Patricia Muñoz

1 reference

6 December 2017

Jesús Palomo Martínez

series ordinal

4

object named as

Jesús Palomo

1 reference

6 December 2017

Claudia Rodríguez

2

1 reference

6 December 2017

Juan F Yañez

series ordinal

5

1 reference

6 December 2017

María Jesús Domínguez

series ordinal

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

6 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 December 2017

volume

4

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

636-643

1 reference

Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Invasive aspergillosis in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Epidemiology of fungal infections in solid organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Clinical aspects of fungal infection in organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Prophylaxis of invasive mycoses in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Tuberculosis in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Lung nodular lesions in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

The growing problem of chronic renal failure after transplantation of a nonrenal organ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Risk factors for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Epidemiology and management of infections after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Oral antifungals as prophylaxis in haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00390.X

10.1111/J.1600-6143.2004.00390.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference